GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Central Pharmaceutical JSC No2 (HSTC:DP2) » Definitions » Debt-to-Equity

Central Pharmaceutical JSC No2 (HSTC:DP2) Debt-to-Equity : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Central Pharmaceutical JSC No2 Debt-to-Equity?

Central Pharmaceutical JSC No2's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. Central Pharmaceutical JSC No2's Total Stockholders Equity for the quarter that ended in . 20 was ₫0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Central Pharmaceutical JSC No2's Debt-to-Equity or its related term are showing as below:

HSTC:DP2's Debt-to-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.48
* Ranked among companies with meaningful Debt-to-Equity only.

Central Pharmaceutical JSC No2 Debt-to-Equity Historical Data

The historical data trend for Central Pharmaceutical JSC No2's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceutical JSC No2 Debt-to-Equity Chart

Central Pharmaceutical JSC No2 Annual Data
Trend
Debt-to-Equity

Central Pharmaceutical JSC No2 Semi-Annual Data
Debt-to-Equity

Competitive Comparison of Central Pharmaceutical JSC No2's Debt-to-Equity

For the Pharmaceutical Retailers subindustry, Central Pharmaceutical JSC No2's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical JSC No2's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Central Pharmaceutical JSC No2's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No2's Debt-to-Equity falls into.



Central Pharmaceutical JSC No2 Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Central Pharmaceutical JSC No2's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Central Pharmaceutical JSC No2's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceutical JSC No2  (HSTC:DP2) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Central Pharmaceutical JSC No2 Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No2's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical JSC No2 (HSTC:DP2) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 9 Tran Thanh Tong, Bach Dang Ward, Hai Ba Trung District, Hanoi, VNM
Central Pharmaceutical JSC No2 is engaged in the Trading of medicinal materials, pharmaceutical materials, chemicals, essential oils, modern medicines, traditional medicine drugs, cosmetics, and nutritious foods. Some of its products include Gentamycin injection solution 80; Genatreson Skin Cream; Ferimax Hard Capsules and others.

Central Pharmaceutical JSC No2 (HSTC:DP2) Headlines

No Headlines